Grants per year
Search results
-
Active
Prot #TNX-103-06: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PH-HFpEF); LEVEL: LEVosimendan to Improve Exercise Lim
Rich, J. D. (PD/PI)
Medpace Clinical Research LLC, Tenax Therapeutics, Inc.
5/7/24 → 5/7/27
Project: Research project